WebNov 12, 2024 · Compass Therapeutics, Inc. and Subsidiaries. Condensed Consolidated Statements of Operations (Unaudited) (In thousands, except per share data) Three Months Ended September 30,: Nine Months Ended ... WebCompass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases. Subscribe to our newsletter Receive daily news updates directly in your inbox.

Compass Therapeutics, Inc. - Web3 Crypto Company Profile, Funding …

Web1 day ago · For instance, the recent clinical collaboration between Compass Therapeutics and Merck was aimed at this. Compass’ CD137 agonist CTX-471 is in phase 1b of clinical evaluation for the treatment ... WebMay 13, 2024 · Compass Therapeutics, Inc. has raised a total of $176.5M in funding over 7 rounds. Their latest funding was raised on Jul 1, 2024 from a Venture - Series Unknown round. Compass Therapeutics, Inc. is registered under the ticker … Alloy Therapeutics raised $42,000,000 / Series D from 8VC and 4 other investors … bismarck prison inmates

Global CD137 Antibodies Clinical Trials & Market Trends Insight …

WebCompass Therapeutics has 5 employees across 2 locations and $203.06 m in total funding,. See insights on Compass Therapeutics including office locations, … WebCompass Therapeutics has 5 employees across 2 locations and $203.06 m in total funding,. See insights on Compass Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. WebNov 2, 2024 · Compass anticipates the gross proceeds from the PIPE to be approximately $80 million, before deducting fees to the placement agents and … bismarck prison roster